Fan Ke-Qin, Zhang Liangming, Song Fangyu, Zhang Yue-Hui, Chen Tong, Cheng Xiang, Su Ning, Zou Yan, Yu Ting, Tan Futing, Xu Wenhao, Yan Zijun
School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Yunnan, Kunming, China.
School of Pharmacy, Dali University, Dali, Yunnan, China.
Front Pharmacol. 2025 Aug 14;16:1604071. doi: 10.3389/fphar.2025.1604071. eCollection 2025.
In recent decades, the pharmacological properties of botanical drugs have been investigated with increasing depth, offering novel insights into their potential for enhancing healthcare. Berberine (BBR) is an alkaloid extracted from the roots, rhizomes and stem tubers of plants such as s, , , and several other plants, which is used not only as an anti-inflammatory and antibacterial agent, but also for the treatment of cancer and chronic diseases. BBR has demonstrated remarkable therapeutic efficacy in the management of disorders affecting the nervous, cardiovascular, and endocrine systems, characterized by its high safety profile and minimal adverse effects. Despite the substantial progress made in understanding BBR's pharmacodynamics, its precise mechanisms of action remain incompletely elucidated and warrant further systematic investigation. This study provides an extensive review of the latest pharmacological findings related to berberine and its therapeutic advancements, offering strong evidence for future research and clinical implementation.
近几十年来,植物药的药理特性得到了越来越深入的研究,为其增强医疗保健潜力提供了新的见解。黄连素(BBR)是从黄连、黄柏、三颗针等植物的根、根茎和块茎中提取的一种生物碱,它不仅用作抗炎和抗菌剂,还用于治疗癌症和慢性疾病。BBR在治疗影响神经、心血管和内分泌系统的疾病方面已显示出显著的治疗效果,其特点是安全性高且副作用极小。尽管在理解BBR的药效学方面取得了重大进展,但其确切的作用机制仍未完全阐明,值得进一步系统研究。本研究对与黄连素相关的最新药理学研究结果及其治疗进展进行了广泛综述,为未来的研究和临床应用提供了有力证据。